Billionaire Stanley Druckenmiller is pouring millions of dollars into two stocks after dumping two of the hottest equities on ...

A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company's ...

Eli Lilly's Mounjaro and Zepbound deliver accelerated weight loss rates compared to Novo Nordisk's Wegovy. Learn why LLY ...

Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for ...

By volume, Augmentin was way higher than Mounjaro with 5,784 units sold during October, compared to just 85 units sale of ...

The deal announced on Thursday, covering Novo's Wegovy and Lilly's Zepbound, will reduce monthly prices for U.S. government ...

The bond market tends to signal broad economic developments well in advance. Emily Bary and Tomi Kilgore explained how the bond market has been indicating that the build-out of generative artificial ...

Hims & Hers Health stock has seen its consensus analyst price target decrease from $47.42 to $46.67 per share. This shift comes as analysts weigh ongoing opportunities for growth against signals of ...

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue.

Shares in Novo Nordisk fell as much as 3 per cent on Friday after the Danish drugmaker and U.S. rival Eli Lilly agreed with ...

Investing.com -- Shares of Novo Nordisk are down 2.5% on Friday after the Trump administration announced agreements with the ...